|
Mutation Information
|
Mutation Site
|
M184V |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Relevant Drug
|
NRTIs |
Literature Information
|
PubMed PMID
|
32715952
|
|
Disease
|
HIV infection/AIDS
|
|
Published Year
|
2020 |
|
Journal
|
HIV research & clinical practice |
|
Title
|
Pooled resistance analyses of darunavir once-daily regimens and formulations across 10 clinical studies of treatment-naïve and treatment-experienced patients with human immunodeficiency virus-1 infection. |
|
Author
|
Lathouwers E,Seyedkazemi S,Luo D,Brown K,De Meyer S,Wong EY |
|
Evidence
|
Among patients receiving D/C/F/TAF (n = 1949), none had post-baseline darunavir, primary PI, or tenofovir RAMs;only two (0.1%) patients developed an emtricitabine RAM, M184V/I.
|
|
|
HIV Mutation Detail Information